The importance of cellular environment to function of the CD44 matrix receptor

Lesley, 1993, CD44 and its interaction with the extracellular matrix, Adv Immunol, 54, 271, 10.1016/S0065-2776(08)60537-4 Toole, 1990, Hyaluronan and its binding proteins, the hyaladherins, Curr Opin Cell Biol, 2, 839, 10.1016/0955-0674(90)90081-O Miyake, 1990, Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition, J Exp Med, 172, 69, 10.1084/jem.172.1.69 Lesley, 1990, Binding of hyaluronic acid to lymphoid cell lines is inhibited by monocional antibodies against Pgp-1, Exp Cell Res, 187, 224, 10.1016/0014-4827(90)90085-O Aruffo, 1990, CD44 is the principal cell surface receptor for hyaluronate, Cell, 61, 1303, 10.1016/0092-8674(90)90694-A Toyama-Sorimachi, 1995, A novel ligand for CD44 is serglycin, a hematopoietic cell lineage-specific proteoglycan. Possible involvement in lymphoid cell adherence and activation, J Biol Chem, 270, 7437, 10.1074/jbc.270.13.7437 Weber, 1996, Receptor-ligand interaction between CD44 and osteopontin (Eta-1), Science, 271, 509, 10.1126/science.271.5248.509 Jalkanen, 1992, Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin, J Cell Biol, 116, 817, 10.1083/jcb.116.3.817 Faassen, 1992, A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion, J Cell Biol, 116, 521, 10.1083/jcb.116.2.521 Gallatin, 1989, Structural homology between lymphocyte receptors for high endothelium and class III extracellular matrix receptor, Proc Natl Acad Sci USA, 86, 4654, 10.1073/pnas.86.12.4654 Knutson, 1996, CD44/chondroitin sulfate proteoglycan and α2β1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes, Mol Biol Cell, 7, 383, 10.1091/mbc.7.3.383 Zahalka, 1995, Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent, J Immunol, 154, 5345, 10.4049/jimmunol.154.10.5345 Rossbach, 1996, An antibody to CD44 enhances hematopoiesis in long-term marrow cultures, Exp Hematol, 24, 221 Khaldoyanidi, 1996, Requirement for CD44 in proliferation and homing of hematopoietic precursor cells, J Leukoc Biol, 60, 579, 10.1002/jlb.60.5.579 Oostendorp, 1996, Adhesion of human hematopoietic progenitor cells to bone-marrow-derived stromal cells is enhanced by antibodies to CD44, Acta Haematol, 95, 243, 10.1159/000203886 Henke, 1996, CD44-related chondroitin sulfate proteoglycan, a cell surface receptor implicated with tumor cell invasion, mediates endothelial cell migration on fibrinogen and invasion into a fibrin matrix, J Clin Invest, 97, 2541, 10.1172/JCI118702 Legras, 1997, CD44-mediated adhesiveness of human hematopoietic progenitors to hyaluronan is modulated by cytokines, Blood, 89, 1905, 10.1182/blood.V89.6.1905 Masellis-Smith, 1996, Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44, Blood, 87, 1891, 10.1182/blood.V87.5.1891.1891 Moffat, 1996, Involvement of CD44 and the cytoskeletal linker protein ankyrin in human neutrophil bacterial phagocytosis, J Cell Physiol, 168, 638, 10.1002/(SICI)1097-4652(199609)168:3<638::AID-JCP16>3.0.CO;2-V Pericle, 1996, CD44 is a cytotoxic triggering molecule on human polymorphonuclear cells, J Immunol, 157, 4657, 10.4049/jimmunol.157.10.4657 Mikecz, 1995, Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis, Nat Med, 1, 558, 10.1038/nm0695-558 McKee, 1996, Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages, J Clin Invest, 98, 2403, 10.1172/JCI119054 Guo, 1996, Identification of a costimulatory molecule rapidly induced by CD40L as CD44H, J Exp Med, 184, 955, 10.1084/jem.184.3.955 Taher, 1996, Signaling through CD44 is mediated by tyrosine kinases — association with p56/ck in T lymphocytes, J Biol Chem, 271, 2863, 10.1074/jbc.271.5.2863 Galandrini, 1996, Tyrosine kinase-dependent activation of human NK cell functions upon triggering through CD44 receptor, Eur J Immunol, 26, 2807, 10.1002/eji.1830261203 Rafi, 1997, Hyaluronate-CD44 interactions can induce murine B-cell activation, Blood, 89, 2901, 10.1182/blood.V89.8.2901 Santos-Argumendo, 1997, CD44-stimulated dendrite formation (‘spreading’) in activated B cells, Immunology, 90, 147, 10.1046/j.1365-2567.1997.00126.x Günthert, 1995, Are CD44 variant isoforms involved in human tumour progression?, Cancer Surv, 24, 19 Stauder, 1995, CD44 variant isoforms in non-Hodgkins lymphoma: a new independent prognostic factor, Blood, 85, 2885, 10.1182/blood.V85.10.2885.bloodjournal85102885 Sy, 1997, CD44 as a marker in human cancers, Curr Opin Oncol, 9, 108, 10.1097/00001622-199701000-00017 Lesley, 1997, CD44 in inflammation and metastasis, Glycoconjugate J, 14, 10.1023/A:1018540610858 Brissett, 1996, The protein fold of the hyaluronate-binding proteoglycan tandem repeat domain of link protein, aggrecan and CD44 is similar to that of the C-type lectin superfamily, FEBS Let, 388, 211, 10.1016/0014-5793(96)00576-5 Kohda, 1996, Solution structure of the link module: a hyaluronan-binding domain involved in extracellular matrix stability and cell migration, Cell, 86, 767, 10.1016/S0092-8674(00)80151-8 DeGrendele, 1996, CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway, J Exp Med, 183, 1119, 10.1084/jem.183.3.1119 Clark, 1996, CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma, J Cell Biol, 134, 1075, 10.1083/jcb.134.4.1075 Hardwick, 1992, Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility, J Cell Biol, 117, 1343, 10.1083/jcb.117.6.1343 Yang, 1994, Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein, EMBO J, 13, 286, 10.1002/j.1460-2075.1994.tb06261.x Sleeman, 1996, Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity, J Cell Biol, 135, 1139, 10.1083/jcb.135.4.1139 Telen, 1996, A blood group-related polymorphism of CD44 abolishes a hyaluronan-binding consensus sequence without preventing hyaluronan binding, J Biol Chem, 271, 7147, 10.1074/jbc.271.12.7147 Peach, 1993, Identification of hyaluronic acid binding sites in the extracellular domain of CD44, J Cell Biol, 122, 257, 10.1083/jcb.122.1.257 Liao, 1995, N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding, J Immunol, 155, 3938, 10.4049/jimmunol.155.8.3938 Katoh, 1995, Glycosylation of CD44 negatively regulates its recognition of hyaluronan, J Exp Med, 182, 419, 10.1084/jem.182.2.419 Lesley, 1995, Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation, J Exp Med, 182, 431, 10.1084/jem.182.2.431 Romarís, 1995, Effect of transforming growth factor-1 and basic fibroblast growth factor on the expression of cell surface proteoglycans in human lung fibroblasts. Enhanced glycanation and fibronectin-binding of CD44 proteoglycan, and down-regulation of glypican, Biochem J, 310, 73, 10.1042/bj3100073 Bartolazzi, 1996, Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan, J Cell Biol, 132, 1199, 10.1083/jcb.132.6.1199 Zheng, 1995, Monoclonal antibodies to CD44 and their influence on hyaluronan recognition, J Cell Biol, 130, 485, 10.1083/jcb.130.2.485 Nakano, 1996, Benzy-α-GalNAc inhibits sialylation of O-glycosidic sugar chains on CD44 and enhances experimental metastatic capacity in B16BL6 melanoma cells, Anticancer Res, 16, 3577 Bennett, 1995, Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons, J Cell Biol, 131, 1623, 10.1083/jcb.131.6.1623 Takahashi, 1996, Keratan sulfate modification of CD44 modulates adhesion to hyaluronate, J Biol Chem, 271, 9490, 10.1074/jbc.271.16.9490 Dasgupta, 1996, O-linked glycosylation modifies CD44 adhesion to hyaluronate in colon carcinoma cells, Biochem Biophys Res Commun, 227, 110, 10.1006/bbrc.1996.1475 Gunthert, 1991, A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells, Cell, 65, 13, 10.1016/0092-8674(91)90403-L Stamenkovic, 1991, The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells, EMBO J, 10, 343, 10.1002/j.1460-2075.1991.tb07955.x He, 1992, Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition, J Cell Biol, 119, 1711, 10.1083/jcb.119.6.1711 Dougherty, 1994, Ligand binding specificity of alternatively spliced CD44 isoforms. Recognition and binding of hyaluronan by CD44R1, J Biol Chem, 269, 9074, 10.1016/S0021-9258(17)37078-3 Van der Voort, 1995, Binding of cell-surface expressed CD44 to hyaluronate is dependent on splicing and cell type, Biochem Biophys Res Commun, 214, 137, 10.1006/bbrc.1995.2267 Yu, 1996, A new alternatively spliced exon between v9 and v10 provides a molecular basis for synthesis of soluble CD44, J Biol Chem, 271, 20603, 10.1074/jbc.271.34.20603 Tanaka, 1993, T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1, Nature, 361, 79, 10.1038/361079a0 Jackson, 1995, Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon, J Cell Biol, 128, 673, 10.1083/jcb.128.4.673 Bennett, 1995, CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor, J Cell Biol, 128, 687, 10.1083/jcb.128.4.687 Isacke, 1994, The role of the cytoplasmic domain in regulating CD44 function, J Cell Sci, 107, 2353, 10.1242/jcs.107.9.2353 Perschl, 1995, Transmembrane domain of CD44 is required for its detergent insolubility in fibroblasts, J Cell Sci, 108, 1033, 10.1242/jcs.108.3.1033 Liu, 1996, A cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid, J Exp Med, 183, 1987, 10.1084/jem.183.5.1987 Guo, 1994, Palmitoylation of CD44 interferes with CD3-mediated signaling in human T lymphocytes, Int Immunol, 6, 213, 10.1093/intimm/6.2.213 Lesley, 1992, Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody, J Exp Med, 175, 257, 10.1084/jem.175.1.257 Pure, 1995, Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain, J Exp Med, 181, 55, 10.1084/jem.181.1.55 Uff, 1995, Hyaluronan binding by CD44 is regulated by a phosphorylation-independent mechanism, Eur J Immunol, 25, 1883, 10.1002/eji.1830250714 Liu, 1996, Binding of CD44 to hyaluronic acid can be induced by multiple signals and requires the CD44 cytoplasmic domain, Cell Immunol, 174, 73, 10.1006/cimm.1996.0295 Lesley, 1993, Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody, Eur J Immunol, 23, 1902, 10.1002/eji.1830230826 Perschl, 1995, Role of CD44 cytoplasmic domain in hyaluronan binding, Eur J Immunol, 25, 495, 10.1002/eji.1830250228 Sheikh, 1996, A di-hydrophobic Leu-Val motif regulates the basolateral localization of CD44 in polarized Madin-Darby canine kidney epithelial cells, J Biol Chem, 271, 12185, 10.1074/jbc.271.21.12185 Naujokas, 1993, The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44, Cell, 74, 257, 10.1016/0092-8674(93)90417-O Tsukita, 1994, ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons, J Cell Biol, 126, 391, 10.1083/jcb.126.2.391 Chiu, 1995, Molecular mechanisms regulating the hyaluronan binding activity of the adhesion protein CD44, J Neurooncol, 26, 231, 10.1007/BF01052626 Droll, 1995, Adhesive interactions between alternatively spliced CD44 isoforms, J Biol Chem, 270, 11567, 10.1074/jbc.270.19.11567 Zheng, 1997, Growth as a solid tumor or reduced glucose concentrations in culture reversibly induce CD44 mediated hyaluronan recognition by CHO cells, J Clin Invest, 100, 10.1172/JCI119635